Emergent BioSolutions' CEO recognized as outstanding international business leader

ROCKVILLE, Md. — The World Trade Center Institute announced March 11 that Emergent BioSolutions Inc.’s chairman and CEO has been named as one of Maryland’s outstanding international business leaders.

WTCI presents the Maryland International Leadership Awards annually to leaders within the state who exemplify entrepreneurial spirit, innovation and global reach.

In a press release, Fuad El-Hibri stated, “Across the globe and on a daily basis, the Emergent team lives out the company mission of protecting life — a commitment to make meaningful contributions to address unmet medical needs especially in underserved markets.

“It is an honor to be recognized for the work that we do and to receive this award on behalf of the team,” he said.

“Mr. El-Hibri recognizes the importance of global markets as key to future growth,” said Deborah M. Kielty, president and executive director of the World Trade Center Institute. 

WTCI was established in Baltimore in 1989 as a nonprofit membership organization to help connect Maryland to the international community. It is a member of the World Trade Center Association, a group of 300 centers located in business communities around the world.

Emergent BioSolutions Inc. focuses on the development, manufacture and commercialization of vaccines and therapeutics that assist the body’s immune system to prevent or treat disease.